Literature DB >> 34522625

A randomized controlled non-inferiority trial of primary care-based facilitated access to an alcohol reduction website (EFAR Spain).

Elsa Caballeria1, Hugo López-Pelayo1, Lidia Segura2, Paul Wallace3, Clara Oliveras1, Estela Díaz2, Jakob Manthey4,5,6, Begoña Baena2, Joan Colom2, Antoni Gual1.   

Abstract

BACKGROUND: Brief interventions (BI) for risky drinkers in primary healthcare have been demonstrated to be cost-effective but they are still poorly implemented. Digital BI seems to be a complementary strategy to overcome some barriers to implementation but there is a scarcity of studies in clinical environments. We present the results of a randomized controlled non-inferiority trial which tests the non-inferiority of facilitated access to a digital intervention (experimental condition) for risky drinkers against a face-to-face BI (control condition) provided by primary healthcare professionals.
METHOD: In a non-inferiority randomized controlled trial, unselected primary healthcare patients (≥ 18 years old) were given a brief introduction and asked to log on to the study website to fill in the 3-item version of the Alcohol Use Disorders Identification Test. Positively screened patients (4+ for women and 5+ for men) received further online assessment (AUDIT, socio-demographic characteristics and EQ-5D-5L) and were automatically randomized to either face-to-face or digital BI (1:1). The primary outcome was the proportion of patients classified as risky drinkers by the digitally administered AUDIT at month 3. A multiple imputation approach for the missing data was performed.
RESULTS: Of the 4499 patients approached by 115 healthcare professionals, 1521 completed the AUDIT-C. Of the 368 positively screened patients, 320 agreed to participate and were randomized to either intervention. At month 3, there were more risky drinkers in the experimental group (59.8%) than in the control group (52%), which was similar to the distribution at baseline and less than the pre-specified margin of 10%. The difference was not significant when accounting for possible confounders.
CONCLUSION: Digital BI was not inferior to face-to-face BI, in line with previous findings and the a priori hypothesis. However, the low power of the final sample, due to the low recruitment and loss to follow-up, limits the interpretation of the findings. New approaches in this field are required to ensure the effective implementation of digital interventions in actual practice.
© 2021 Published by Elsevier B.V.

Entities:  

Keywords:  Primary healthcare; Risky alcohol use; Screening and brief intervention; eHealth

Year:  2021        PMID: 34522625      PMCID: PMC8424207          DOI: 10.1016/j.invent.2021.100446

Source DB:  PubMed          Journal:  Internet Interv        ISSN: 2214-7829


  29 in total

Review 1.  [The Spanish version of EuroQol: a description and its applications. European Quality of Life scale].

Authors:  X Badia; M Roset; S Montserrat; M Herdman; A Segura
Journal:  Med Clin (Barc)       Date:  1999       Impact factor: 1.725

Review 2.  Alcohol Use Disorders in Primary Health Care: What Do We Know and Where Do We Go?

Authors:  Jürgen Rehm; Peter Anderson; Jakob Manthey; Kevin D Shield; Pierluigi Struzzo; Marcin Wojnar; Antoni Gual
Journal:  Alcohol Alcohol       Date:  2015-11-15       Impact factor: 2.826

Review 3.  Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the U.S. Preventive Services Task Force.

Authors:  Evelyn P Whitlock; Michael R Polen; Carla A Green; Tracy Orleans; Jonathan Klein
Journal:  Ann Intern Med       Date:  2004-04-06       Impact factor: 25.391

4.  On-line randomized controlled trial of an internet based psychologically enhanced intervention for people with hazardous alcohol consumption.

Authors:  Paul Wallace; Elizabeth Murray; Jim McCambridge; Zarnie Khadjesari; Ian R White; Simon G Thompson; Eleftheria Kalaitzaki; Christine Godfrey; Stuart Linke
Journal:  PLoS One       Date:  2011-03-09       Impact factor: 3.240

5.  A randomised controlled non-inferiority trial of primary care-based facilitated access to an alcohol reduction website (EFAR Spain): the study protocol.

Authors:  Hugo López-Pelayo; Paul Wallace; Lidia Segura; Laia Miquel; Estela Díaz; Lidia Teixidó; Begoña Baena; Pierliugio Struzzo; Jorge Palacio-Vieira; Cristina Casajuana; Joan Colom; Antoni Gual
Journal:  BMJ Open       Date:  2014-12-31       Impact factor: 2.692

6.  Validation of the AUDIT-C in adults seeking help with their drinking online.

Authors:  Zarnie Khadjesari; Ian R White; Jim McCambridge; Louise Marston; Paul Wallace; Christine Godfrey; Elizabeth Murray
Journal:  Addict Sci Clin Pract       Date:  2017-01-04

Review 7.  Effectiveness of brief alcohol interventions in primary care populations.

Authors:  Eileen Fs Kaner; Fiona R Beyer; Colin Muirhead; Fiona Campbell; Elizabeth D Pienaar; Nicolas Bertholet; Jean B Daeppen; John B Saunders; Bernard Burnand
Journal:  Cochrane Database Syst Rev       Date:  2018-02-24

Review 8.  Development of a psychologically enhanced interactive online intervention for hazardous drinking.

Authors:  Stuart Linke; Jim McCambridge; Zarnie Khadjesari; Paul Wallace; Elizabeth Murray
Journal:  Alcohol Alcohol       Date:  2008-08-07       Impact factor: 2.826

9.  Implementing referral to an electronic alcohol brief advice website in primary healthcare: results from the ODHIN implementation trial.

Authors:  Preben Bendtsen; Ulrika Müssener; Nadine Karlsson; Hugo López-Pelayo; Jorge Palacio-Vieira; Joan Colom; Antoni Gual; Jillian Reynolds; Paul Wallace; Lidia Segura; Peter Anderson
Journal:  BMJ Open       Date:  2016-06-16       Impact factor: 2.692

10.  Randomised controlled non-inferiority trial of primary care-based facilitated access to an alcohol reduction website.

Authors:  Paul Wallace; Pierliugi Struzzo; Roberto Della Vedova; Francesca Scafuri; Costanza Tersar; Charilaos Lygidakis; Richard McGregor; Emanuele Scafato; Rachael Hunter; Nick Freemantle
Journal:  BMJ Open       Date:  2017-11-03       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.